Tricuspid atresia laboratory findings: Difference between revisions

Jump to navigation Jump to search
 
Line 5: Line 5:
{{CMG}} '''Associate Editor-In-Chief:'''{{Sara.Zand}}  
{{CMG}} '''Associate Editor-In-Chief:'''{{Sara.Zand}}  
==Overview==
==Overview==
In [[cyanotic]] older patients laboratory finding may include:[[Polycythemia]] due to secondary [[erythrocytosis]], elevated [[prothrombin time]] and [[partial thromboplastin time]], decreased levels of factors 5,7,8,9: qualitative and quantitative, [[platelet disorder]], increased [[fibrinolysis]] and paradoxical [[thrombotic]] tendency, [[proteinuria]], [[hyperuricemia]], [[renal failure]], [[uric acid]] [[nephrolithiasis]]
In [[cyanotic]] older patients laboratory findings may include:[[Polycythemia]] due to secondary [[erythrocytosis]], elevated [[prothrombin time]] and [[partial thromboplastin time]], decreased levels of factors 5,7,8,9: qualitative and quantitative, [[platelet disorder]], increased [[fibrinolysis]] and paradoxical [[thrombotic]] tendency, [[proteinuria]], [[hyperuricemia]], [[renal failure]], [[uric acid]] [[nephrolithiasis]]
 


==[[Tricuspid atresia]] laboratory findings==
==[[Tricuspid atresia]] laboratory findings==

Latest revision as of 16:57, 8 November 2020

Tricuspid atresia Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Tricuspid Atresia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenarios

Pregnancy

Case Studies

Case #1

Tricuspid atresia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid atresia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid atresia laboratory findings

CDC on Tricuspid atresia laboratory findings

Tricuspid atresia laboratory findings in the news

Blogs on Tricuspid atresia laboratory findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tricuspid atresia laboratory findings

Tricuspid atresia Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Tricuspid Atresia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenarios

Pregnancy

Case Studies

Case #1

Tricuspid atresia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid atresia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid atresia laboratory findings

CDC on Tricuspid atresia laboratory findings

Tricuspid atresia laboratory findings in the news

Blogs on Tricuspid atresia laboratory findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tricuspid atresia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief:Sara Zand, M.D.[2]

Overview

In cyanotic older patients laboratory findings may include:Polycythemia due to secondary erythrocytosis, elevated prothrombin time and partial thromboplastin time, decreased levels of factors 5,7,8,9: qualitative and quantitative, platelet disorder, increased fibrinolysis and paradoxical thrombotic tendency, proteinuria, hyperuricemia, renal failure, uric acid nephrolithiasis

Tricuspid atresia laboratory findings

In cyanotic older patients laboratory finding may include:[1]

References

  1. Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N (2017). "Coagulopathies in cyanotic cardiac patients: An analysis with three point - of - care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer)". Ann Card Anaesth. 20 (2): 212–218. doi:10.4103/aca.ACA_4_17. PMC 5408528. PMID 28393783.

Template:WH Template:WS